MM Mello, DM Studdert, TA Brennan - The New England Journal of Medicine, 2009 - nejm.highwire.org In regulating the promotion of unapproved, or off-label, uses of approved drugs,
the Food and Drug Administration (FDA) has sought to strike a balance between
supporting the ability of phy- sicians to prescribe according to their best ... Cited by 1 - Related articles - All 3 versions